Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$330K Sell
9,946
-10,984
-52% -$413K 0.04% 178
2025
Q4
$819K Buy
20,930
+3,196
+18% +$133K 0.08% 86
2025
Q3
$797K Sell
17,734
-18,198
-51% -$858K 0.09% 92
2025
Q2
$1.76M Buy
35,932
+29,169
+431% +$1.63M 0.2% 54
2025
Q1
$383K Buy
6,763
+1,122
+20% +$63.1K 0.05% 172
2024
Q4
$324K Sell
5,641
-2,185
-28% -$124K 0.05% 183
2024
Q3
$410K Sell
7,826
-31,126
-80% -$1.62M 0.06% 198
2024
Q2
$2.11M Buy
38,952
+27,207
+232% +$1.49M 0.34% 44
2024
Q1
$680K Sell
11,745
-45,563
-80% -$2.34M 0.12% 95
2023
Q4
$2.81M Buy
57,308
+148
+0.3% +$6.99K 0.5% 49
2023
Q3
$2.46M Buy
57,160
+32,484
+132% +$1.44M 0.76% 40
2023
Q2
$1.13M Buy
+24,676
New +$1.02M 0.34% 69

Other funds holding CPRT

Cynosure Group's CPRT Position: Q1 2026 in Review

Cynosure Group reduced its Copart (CPRT) stake by 52% in Q1 2026, selling an estimated $413K and leaving 9,946 shares worth $330K. The position accounts for 0.04% of the portfolio, ranked #178.

Cynosure Group first reported a position in CPRT in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.81M in Q4 2023. 1,077 funds tracked by Wall St. Rank hold CPRT as of Q1 2026.

  • Cynosure Group held 9,946 shares of Copart worth $330K as of Q1 2026.
  • Cynosure Group sold 10,984 Copart shares in Q1 2026, an estimated $413K.
  • Copart made up 0.04% of Cynosure Group's portfolio in Q1 2026, its #178 holding.
  • Cynosure Group first reported a position in Copart in Q2 2023 and has held it in 12 quarters since.
  • Cynosure Group's Copart position peaked at $2.81M in Q4 2023.
  • 1,077 funds tracked by Wall St. Rank held Copart as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.